Malte Peters - 17 Jun 2024 Form 4 Insider Report for HOOKIPA Pharma Inc. (HOOK)

Role
Director
Signature
/s/ Reinhard Kandera, Attorney-in-Fact
Issuer symbol
HOOK
Transactions as of
17 Jun 2024
Net transactions value
$0
Form type
4
Filing time
18 Jun 2024, 16:15:33 UTC
Previous filing
07 Jun 2024
Next filing
24 Jul 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HOOK Stock Option (Right to Buy) Award $0 +49,000 $0.000000 49,000 17 Jun 2024 Common Stock 49,000 $0.7100 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option award shall vest and become fully exercisable on the earlier to occur of (a) June 17, 2025 and (b) the date of the Issuer's next annual meeting of its stockholders.